Healthcare provider profile · identity verified

Chadwick Byle, MD

Sports Medicine · KANSAS CITY, MO · NPI 1336535145

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	763	216
Amlodipine Besylate	Amlodipine Besylate	320	95
Lisinopril	Lisinopril	320	85
Omeprazole	Omeprazole	307	91
Levothyroxine Sodium	Levothyroxine Sodium	272	77
Rosuvastatin Calcium	Rosuvastatin Calcium	228	71
Losartan Potassium	Losartan Potassium	194	56
Pantoprazole Sodium	Pantoprazole Sodium	175	61
Tamsulosin Hcl	Tamsulosin Hcl	175	52
Metformin Hcl	Metformin Hcl	174	38
Gabapentin	Gabapentin	157	56
Hydrochlorothiazide	Hydrochlorothiazide	157	50
Carvedilol	Carvedilol	149	42
Fluticasone Propionate	Fluticasone Propionate	139	51
Zolpidem Tartrate	Zolpidem Tartrate	136	31
Meloxicam	Meloxicam	134	39
Escitalopram Oxalate	Escitalopram Oxalate	133	37
Metoprolol Succinate	Metoprolol Succinate	123	41
Jardiance	Empagliflozin	117	35
Famotidine	Famotidine	116	30
Bupropion Xl	Bupropion Hcl	110	34
Furosemide	Furosemide	108	37
Ozempic	Semaglutide	107	23
Metformin Hcl Er	Metformin Hcl	106	27
Simvastatin	Simvastatin	106	25
Trazodone Hcl	Trazodone Hcl	104	30
Allopurinol	Allopurinol	100	27
Albuterol Sulfate Hfa	Albuterol Sulfate	93	36
Olmesartan Medoxomil	Olmesartan Medoxomil	93	37
Montelukast Sodium	Montelukast Sodium	83	30
Sertraline Hcl	Sertraline Hcl	78	19
Eliquis	Apixaban	76	20
Clopidogrel	Clopidogrel Bisulfate	70	17
Prednisone	Prednisone	70	48
Tizanidine Hcl	Tizanidine Hcl	70	24
Tramadol Hcl	Tramadol Hcl	67	21
Celecoxib	Celecoxib	63	21
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	53	23
Ezetimibe	Ezetimibe	53	17
Duloxetine Hcl	Duloxetine Hcl	52	16
Metoprolol Tartrate	Metoprolol Tartrate	52	14
Mupirocin	Mupirocin	52	33
Warfarin Sodium	Warfarin Sodium	50	suppressed
Potassium Chloride	Potassium Chloride	49	20
Xarelto	Rivaroxaban	48	12
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Citalopram Hbr	Citalopram Hydrobromide	44	12
Ropinirole Hcl	Ropinirole Hcl	44	11
Glimepiride	Glimepiride	42	suppressed
Finasteride	Finasteride	41	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	40	14
Alendronate Sodium	Alendronate Sodium	39	17
Pregabalin	Pregabalin	38	suppressed
Mirtazapine	Mirtazapine	35	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	35	suppressed
Valsartan	Valsartan	31	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	30	24
Fluoxetine Hcl	Fluoxetine Hcl	29	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	12
Irbesartan	Irbesartan	28	suppressed
Pravastatin Sodium	Pravastatin Sodium	28	suppressed
Sucralfate	Sucralfate	27	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	27	21
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	26	23
Donepezil Hcl	Donepezil Hcl	26	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	26	suppressed
Estradiol	Estradiol	26	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	26	suppressed
Trulicity	Dulaglutide	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	25	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	25	suppressed
Spironolactone	Spironolactone	25	suppressed
Synthroid	Levothyroxine Sodium	25	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Aripiprazole	Aripiprazole	23	suppressed
Buspirone Hcl	Buspirone Hcl	23	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	23	suppressed
Olanzapine	Olanzapine	23	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	22	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	22	20
Ketoconazole	Ketoconazole	21	suppressed
Ondansetron Odt	Ondansetron	21	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	20	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Linzess	Linaclotide	20	suppressed
Ibuprofen	Ibuprofen	19	suppressed
Latanoprost	Latanoprost	19	suppressed
Naltrexone Hcl	Naltrexone Hcl	19	suppressed
Novolog Flexpen	Insulin Aspart	19	suppressed
Benazepril Hcl	Benazepril Hcl	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	18	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	18	suppressed
Glipizide Er	Glipizide	18	suppressed
Hydralazine Hcl	Hydralazine Hcl	18	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	18	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	17	suppressed
Testosterone Cypionate	Testosterone Cypionate	17	suppressed
Torsemide	Torsemide	17	suppressed
Valacyclovir	Valacyclovir Hcl	17	suppressed
Acyclovir	Acyclovir	16	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	16	suppressed
Clotrimazole	Clotrimazole	16	suppressed
Terbinafine Hcl	Terbinafine Hcl	16	suppressed
Clonidine Hcl	Clonidine Hcl	15	suppressed
Diclofenac Sodium	Diclofenac Sodium	15	13
Januvia	Sitagliptin Phosphate	15	suppressed
Oxcarbazepine	Oxcarbazepine	15	suppressed
Telmisartan	Telmisartan	15	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	14	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	14	suppressed
Eszopiclone	Eszopiclone	13	suppressed
Fluconazole	Fluconazole	13	suppressed
Guanfacine Hcl Er	Guanfacine Hcl	13	suppressed
Ipratropium Bromide	Ipratropium Bromide	13	suppressed
Methocarbamol	Methocarbamol	13	suppressed
Alprazolam	Alprazolam	12	suppressed
Arexvy	Rsvpref3 Antigen/As01e/Pf	12	12
Lantus	Insulin Glargine,hum.Rec.Anlog	12	suppressed
Topiramate	Topiramate	12	suppressed
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	11	11
Atenolol	Atenolol	11	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Doxycycline Hyclate	Doxycycline Hyclate	11	suppressed
Ondansetron Hcl	Ondansetron Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error